-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
November 01, 2016 - Excluded from the review were studies
conducted among patients with low back pain related to cancer, infection
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_consumer.pdf
February 01, 2016 - Vision problems
��Fever
��Memory problems
��Changes in the
taste of food
��Upper respiratory
tract infection
-
effectivehealthcare.ahrq.gov/products/genitourinary-syndrome/protocol
-
effectivehealthcare.ahrq.gov/products/urinary-incontinence-treatment/research
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - Complete reporting of treatment-related mortality, secondary
malignancy, serious infections, and veno-occlusive … transplant-related
complications (1
engraftment syndrome, 1
septic shock with
multiorgan failure, and 1
fungal infection … Research
Design
Sample size;
Years;
Location;
Followup
Treatment(s) Outcomes Status
FUNGAL INFECTION … Voriconazole
Compared With
Itraconazole in
Preventing Fungal
Infections in Patients
Undergoing … Toxicity
Infection
Safety
This study
is ongoing,
but not
recruiting
participants.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-199-skin-cancer.pdf
December 01, 2017 - • Serious adverse events,
events leading to treatment
discontinuation, and treatment site
infections … Infections at the treatment
site were described in 5.5 percent of lesions with surgical
treatments … No information on
infections was available for treatments that destroy lesions
with heat or cold or … Serious
Adverse
Events (95%
CI)
Adverse
Events:
Pain After
Treatment
(95% CI)
Adverse
Events:
Infection … The
outcome of infection at the treatment site was reported in a
single RCT (36 participants) at 0
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
February 22, 2012 - ., forced expiratory volume
1), pulmonary symptoms (e.g., dyspnea, hemoptysis), respiratory tract infection … recurrence, lung function (e.g., FEV1), pulmonary symptoms (e.g., dyspnea, bleeding), and
respiratory tract infection … Intermediate outcomes
Local control
Lung function (e.g.,
FEV1)
Dyspnea
Hemoptysis
Infections
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
January 15, 2016 - TEP reviewer #3 Introduction line 9 : "infection" suggest change to ulceration as infection
of infantile
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - exacerbations due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus
pneumoniae infection … often require chronic use of inhaled, intravenous, or oral antibiotics to prevent or
treat acute infections … exacerbations due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae
infection … issues
(i.e., long-acting bronchodilators, inhaled glucocorticosteroids), and antibiotics for lung infections
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-afib-update_research-protocol-amended.pdf
October 27, 2017 - hemorrhage
• Major bleed
• Minor bleed
Other clinical outcomes:
• Mortality
• Myocardial infarction
• Infection … outcomes:
o Mortality
• All-cause mortality
• Cardiovascular mortality
o Myocardial infarction
o Infection … Mesh] OR "HIV
Long-Term Survivors"[Mesh] OR "HIV-Associated Lipodystrophy Syndrome"[Mesh] OR "HIV
Infections
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-epilepsy-amended-protocol.pdf
March 07, 2021 - anxiety
• Caregiver quality of life
• General health status
• Cost of treatment
• Adverse events (infection … Adverse effects:
Infection, new neurological deficits, surgical
complications, irritability, somnolence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
October 25, 2022 - Infection risk presented
derives from underlying disease, or sedation; there is risk
of infection with … Surgery
is elective, bleeding infection, stroke, hydrocephalus and
death occur.
-
effectivehealthcare.ahrq.gov/products/liver-cancer-therapy/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
May 01, 2006 - Risk of
hepatitis B infection is estimated to be 1 in 220,000 per
unit of blood transfused.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_research-protocol.pdf
June 11, 2014 - www.effectivehealthcare.ahrq.gov
Published online: June 11, 2014
2
overdistention of the uterus, infection … www.effectivehealthcare.ahrq.gov
Published online: June 11, 2014
3
and surgeries can increase the risk of infection … include
fever, vomiting, vascular perforation, uterine ischemia, thrombosis, fertility loss, and
infection
-
effectivehealthcare.ahrq.gov/products/infantile-hemangioma/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
February 01, 2013 - access site
complications, renal dysfunction, anaphylaxis, arrhythmias, stent thrombosis,
bleeding, infections … access site
complications, renal dysfunction, anaphylaxis, arrhythmias, stent thrombosis,
bleeding, infections … reported radiation
exposure, contrast reactions, access site complications, stent thrombosis, or
infection … systematically reported radiation exposure,
contrast reactions, access site complications, stent thrombosis or infection … access site complications, renal dysfunction, anaphylaxis, arrhythmias, stent
thrombosis, bleeding, infections
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
June 01, 2013 - Topiramate increased risk of paresthesia,
upper respiratory tract infection, and weight loss. … demonstrated significant
increase in risk of weight loss, paresthesia, and upper
respiratory tract infection … unintended weight loss (95% CI,
24 to 150) and 105 would be diagnosed with upper
respiratory tract infection … divalproex
sodium, 1,000 mg/day, and increased risk of weight loss,
paresthesia, and respiratory tract infection
-
effectivehealthcare.ahrq.gov/products/advanced-care-decision-aids/research-protocol
-
effectivehealthcare.ahrq.gov/products/hepatitis-c/research-protocol